Global stocks are picking up the pace. While the S&P 500 has jumped almost 11% in the past month, the EAFA index of large- and mid-cap stocks based in countries other than the U.S. and Canada has ...

AZN records a 50% share of gross profits from this drug’s sales in major ex-U.S. markets and 25% of brand revenues from the rest of the world markets via partner Sanofi SNY. The company also ...

AZN) stands against the other best ADR stocks to invest in. An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank, representing shares of a foreign company. ADRs enable U.S ...

LONDON, April 29 (Reuters) - The chief executive of AstraZeneca (AZN.L), opens new tab said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S. levies tariffs on ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other profitable European stocks to buy. After the U.S. Presidential elections, the global ...

Recently, the firm reported phase-three data for Mounjaro, more than a year after the drug was approved in the U.S. In short ... Like all but one analyst covering AZN stock, I am bullish.

AstraZeneca (NASDAQ:AZN) has changed several key management positions ... According to one person familiar with the matter, the U.K.-headquartered pharma giant wants to "show that there has ...